AR051626A1 - Compuestos de imidazo[1,2-a]piridina,procesos para preparar dichos compuestos,composiciones farmaceuticas que los contienen y usos como moduladores del receptor gaba a - Google Patents
Compuestos de imidazo[1,2-a]piridina,procesos para preparar dichos compuestos,composiciones farmaceuticas que los contienen y usos como moduladores del receptor gaba aInfo
- Publication number
- AR051626A1 AR051626A1 ARP050104693A ARP050104693A AR051626A1 AR 051626 A1 AR051626 A1 AR 051626A1 AR P050104693 A ARP050104693 A AR P050104693A AR P050104693 A ARP050104693 A AR P050104693A AR 051626 A1 AR051626 A1 AR 051626A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkyl
- substituted
- alkynyl
- cycloalkyl
- alkenyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Anesthesiology (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Reivindicacion 1. Un compuesto de imidazo[1,2-a]piridina de formula (1) así como las correspondientes sales farmacéuticamente aceptables; caracterizado porque R1 y R2 se seleccionan independientemente del grupo que consiste en H alquil C1-6 lineal o ramificado, alquenil C2-6, alquinil C2-6, haloalquil C1-6, -O-alquil C1-6, F, Cl, y Br; R3 se selecciona del grupo que consiste en H, alquil C1-6 lineal o ramificado, cicloalquil C3-6, cicloalquil C3-6-alquil C1-6, alquenil C2-6, alquenil C2-6- alquil C1-6, alquinil C2-6, alquinil C2-6-alquil C1-6; R4 se selecciona del grupo que consiste e H, haloalquil C2-6, cicloalquil C3-5, cicloalquil C3-6-alquil C1-6, alquinil C2-6-alquil C1-6, alquil C1-6-O-alquil C1-6, alquil C1-6-NH-alquil C1-6, alquil C1-6-N(dialquil C1-6), -OR5, -NHR5, -NR5R6, como se muestra en el resto de formula (2) fenilalquil C2-6, fenialquenil C2-6, naftil, naftil monosustituido, naftil disustituido, naftilalquil C1-6, naftilalquenil C2-6, furil, furil sustituido, benzofuril, benzofuril sustituido, pirrolil, pirrolil sustituido, isoxazolil, isoxazolil sustituido, benzoisoxazolil, benzoisoxazolil sustituido, imidazolil, imidazolil sustituido, benzoimidazolil, benzoimidazolil sustituido, indolil, indolil sustituido, pirazolil, pirazolil sustituido, tienil, tienil sustituido, benzotienil, benzotienil sustituido, tiazolil, tiazolil sustituido, benzotiazolil, benzotiazolil sustituido, quinolinil, quinolinil sustituido, isoquinolinil, isoquinolinil sustituido, piridil, piridil sustituido, pirazinil, pirazinil sustituido, 6-oxo-1,4,5,6-tetrahidropiridazinil, 6-oxo-1,4,5,6-tetrahidropiridazinil sustituido, tiadiazolil, tiadiazolil sustituido, isotiazolil, isotiazolil sustituido, tienilmetil, 2- oxocromenil, 2-oxocromenol sustituido, 2-(furan-2-il)vinil, oxazolil, oxazolil sustituido, y benzisoxazolil; R5 y R6 se seleccionan independientemente del grupo que consiste en H, alquil C1-6 lineal o ramificado, fenilalquil C1-6, haloalquil C1-6, cicloalquil C3-6, cicloalquil C3-6-alquil C1-6, alquenil C2-6 y alquinil C2-6, alquenil C2-6-alquil C1-6, alquinil C2-6-alquil C1-6, fenil, fenil sustituido, heteroaril, heteroaril sustituido; y R7 y R8 se seleccionan independientemente del grupo que consiste en alquil C2-6 lineal o ramificado, cicloalquil C3-6, alquenil C2-6, alquinil C2-6, -OH, -O-alquil C1-6, -SH, -S-alquil C1-6, halo-alquil C1-6, omega, omega, omega-trifluoroalquil C1-6, -NHalquil C1-6, -Ndialquil C1-6, -NO2, -CN, - SO2alquil C1-6, -COalquil C1-6, -COOalquil C1-6, -CO-NHalquil C1-6, -CONdialquil C1-6, fenil, fenil sustituido, heteroaril y heteroaril sustituido.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04105698 | 2004-11-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR051626A1 true AR051626A1 (es) | 2007-01-24 |
Family
ID=34929843
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP050104693A AR051626A1 (es) | 2004-11-11 | 2005-11-09 | Compuestos de imidazo[1,2-a]piridina,procesos para preparar dichos compuestos,composiciones farmaceuticas que los contienen y usos como moduladores del receptor gaba a |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US20080200473A1 (es) |
| EP (1) | EP1814880B1 (es) |
| JP (1) | JP2008519805A (es) |
| KR (1) | KR20070084026A (es) |
| CN (1) | CN101065377B (es) |
| AR (1) | AR051626A1 (es) |
| AT (1) | ATE421962T1 (es) |
| AU (1) | AU2005303811A1 (es) |
| BR (1) | BRPI0517796A (es) |
| CA (1) | CA2585315A1 (es) |
| DE (1) | DE602005012598D1 (es) |
| DK (1) | DK1814880T3 (es) |
| ES (1) | ES2321858T3 (es) |
| IL (1) | IL182963A0 (es) |
| MX (1) | MX2007005611A (es) |
| NO (1) | NO20072831L (es) |
| PA (1) | PA8652101A1 (es) |
| PE (1) | PE20060967A1 (es) |
| PL (1) | PL1814880T3 (es) |
| PT (1) | PT1814880E (es) |
| RU (1) | RU2007121864A (es) |
| TW (1) | TWI357412B (es) |
| UY (1) | UY29204A1 (es) |
| WO (1) | WO2006051063A1 (es) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2003220222A1 (en) | 2002-03-13 | 2003-09-29 | Signum Biosciences, Inc. | Modulation of protein methylation and phosphoprotein phosphate |
| EP1843734A4 (en) | 2005-02-03 | 2008-09-10 | Signum Biosciences Inc | COMPOSITIONS AND METHODS FOR ENHANCING COGNITIVE FUNCTION |
| US7923041B2 (en) | 2005-02-03 | 2011-04-12 | Signum Biosciences, Inc. | Compositions and methods for enhancing cognitive function |
| EP1845098A1 (en) * | 2006-03-29 | 2007-10-17 | Ferrer Internacional, S.A. | Imidazo[1,2-b]pyridazines, their processes of preparation and their use as GABA receptor ligands |
| ATE438632T1 (de) * | 2006-05-31 | 2009-08-15 | Hoffmann La Roche | Aryl-4-ethinylisoxazolderivate |
| US20100209345A1 (en) * | 2006-08-24 | 2010-08-19 | Australian Nuclear Science & Technology Organisation | Fluorinated Ligands for Targeting Peripheral Benzodiazepine Receptors |
| CN102014897B (zh) | 2008-04-21 | 2015-08-05 | 西格纳姆生物科学公司 | 化合物、组合物和其制备方法 |
| AU2009249186B2 (en) * | 2008-05-19 | 2014-05-22 | Sunovion Pharmaceuticals Inc. | Imidazo [1, 2-a] pyridine compounds as GABA-A receptor modulators |
| WO2010045615A2 (en) | 2008-10-16 | 2010-04-22 | Cenomed Biosciences, Llc | Treatment of organophosphate exposure with ocinaplon |
| EP2376490B1 (en) * | 2008-12-04 | 2013-01-23 | Proximagen Limited | Imidazopyridine compounds |
| WO2011057145A2 (en) | 2009-11-05 | 2011-05-12 | University Of Notre Dame Du Lac | Imidazo[1,2-a] pyridine compounds, synthesis thereof, and methods of using same |
| US8729271B2 (en) | 2010-09-17 | 2014-05-20 | Taisho Pharmaceutical Co., Ltd | Glycine transporter inhibiting substances |
| US10919888B2 (en) | 2015-09-17 | 2021-02-16 | University Of Notre Dame Du Lac | Benzyl amine-containing heterocyclic compounds and compositions useful against mycobacterial infection |
| CN106906486B (zh) * | 2017-02-22 | 2018-12-11 | 华南理工大学 | 3-溴-2-苯基-咪唑并[1,2-α]吡啶类衍生物的电化学合成方法 |
| EP4096668A4 (en) * | 2020-01-29 | 2024-02-28 | Foghorn Therapeutics Inc. | Compounds and uses thereof |
| WO2024222712A1 (zh) * | 2023-04-24 | 2024-10-31 | 上海赛默罗生物科技有限公司 | 咪唑并吡啶或咪唑并吡嗪类化合物、其制备方法、药物组合物和用途 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2568880B1 (fr) * | 1984-08-07 | 1986-12-12 | Synthelabo | Derives d'acylaminomethyl-3 imidazo(1,2-a)pyridines, leur preparation et leur application en therapeutique |
| FR2593818B1 (fr) * | 1986-02-05 | 1988-04-29 | Synthelabo | Derives d'acylaminomethyl-3 imidazo(1,2-a)pyridine, leur preparation et leur application en therapeutique |
| EP0234970B1 (fr) * | 1986-01-22 | 1991-04-17 | Synthelabo | Dérivés d'acylaminométhyl-3 imidazo[1,2-a]pyridines, leur préparation et leur application en thérapeutique |
| FR2593181B1 (fr) * | 1986-01-22 | 1988-04-01 | Synthelabo | Derives d'acylaminomethyl-3 imidazo(1,2-a)pyridines, leur preparation et leur application en therapeutique |
| WO2004066930A2 (en) * | 2003-01-27 | 2004-08-12 | Arthur Zaks | Method for inducing pain relief using imidazo[1,2-a]pyridine derivatives |
-
2005
- 2005-11-04 PT PT05808135T patent/PT1814880E/pt unknown
- 2005-11-04 JP JP2007540634A patent/JP2008519805A/ja active Pending
- 2005-11-04 CN CN2005800386913A patent/CN101065377B/zh not_active Expired - Fee Related
- 2005-11-04 DK DK05808135T patent/DK1814880T3/da active
- 2005-11-04 AU AU2005303811A patent/AU2005303811A1/en not_active Abandoned
- 2005-11-04 AT AT05808135T patent/ATE421962T1/de active
- 2005-11-04 MX MX2007005611A patent/MX2007005611A/es active IP Right Grant
- 2005-11-04 BR BRPI0517796-0A patent/BRPI0517796A/pt not_active IP Right Cessation
- 2005-11-04 PL PL05808135T patent/PL1814880T3/pl unknown
- 2005-11-04 DE DE602005012598T patent/DE602005012598D1/de active Active
- 2005-11-04 US US11/667,494 patent/US20080200473A1/en not_active Abandoned
- 2005-11-04 WO PCT/EP2005/055753 patent/WO2006051063A1/en active Application Filing
- 2005-11-04 ES ES05808135T patent/ES2321858T3/es active Active
- 2005-11-04 RU RU2007121864/04A patent/RU2007121864A/ru not_active Application Discontinuation
- 2005-11-04 KR KR1020077010318A patent/KR20070084026A/ko not_active Application Discontinuation
- 2005-11-04 CA CA002585315A patent/CA2585315A1/en not_active Abandoned
- 2005-11-04 EP EP05808135A patent/EP1814880B1/en not_active Not-in-force
- 2005-11-07 PE PE2005001302A patent/PE20060967A1/es not_active Application Discontinuation
- 2005-11-08 TW TW094139042A patent/TWI357412B/zh not_active IP Right Cessation
- 2005-11-08 PA PA20058652101A patent/PA8652101A1/es unknown
- 2005-11-09 AR ARP050104693A patent/AR051626A1/es not_active Application Discontinuation
- 2005-11-10 UY UY29204A patent/UY29204A1/es not_active Application Discontinuation
-
2007
- 2007-05-03 IL IL182963A patent/IL182963A0/en unknown
- 2007-06-04 NO NO20072831A patent/NO20072831L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| DE602005012598D1 (de) | 2009-03-19 |
| CN101065377A (zh) | 2007-10-31 |
| DK1814880T3 (da) | 2009-05-18 |
| BRPI0517796A (pt) | 2008-10-28 |
| CA2585315A1 (en) | 2006-05-18 |
| WO2006051063A1 (en) | 2006-05-18 |
| EP1814880B1 (en) | 2009-01-28 |
| KR20070084026A (ko) | 2007-08-24 |
| PA8652101A1 (es) | 2006-10-13 |
| AU2005303811A1 (en) | 2006-05-18 |
| PE20060967A1 (es) | 2006-09-20 |
| JP2008519805A (ja) | 2008-06-12 |
| UY29204A1 (es) | 2006-01-31 |
| US20080200473A1 (en) | 2008-08-21 |
| ATE421962T1 (de) | 2009-02-15 |
| CN101065377B (zh) | 2011-07-27 |
| RU2007121864A (ru) | 2008-12-20 |
| PT1814880E (pt) | 2009-04-23 |
| NO20072831L (no) | 2007-08-01 |
| PL1814880T3 (pl) | 2009-07-31 |
| IL182963A0 (en) | 2007-08-19 |
| MX2007005611A (es) | 2007-07-11 |
| EP1814880A1 (en) | 2007-08-08 |
| ES2321858T3 (es) | 2009-06-12 |
| TWI357412B (en) | 2012-02-01 |
| TW200624432A (en) | 2006-07-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR051626A1 (es) | Compuestos de imidazo[1,2-a]piridina,procesos para preparar dichos compuestos,composiciones farmaceuticas que los contienen y usos como moduladores del receptor gaba a | |
| AR114922A1 (es) | Moléculas que tienen utilidad plaguicida, y composiciones y procesos, relacionados con ellas | |
| EA200971081A1 (ru) | Пуриновые производные и их применение в качестве модуляторов толл-подобного рецептора 7 | |
| PE20191613A1 (es) | Compuestos de pirazolo[1,5-a]piridina sustituidos como inhibidores de la quinasa ret | |
| MA49061A (fr) | Dérivés 4-sulfonylaminocarbonylquinoline pour augmenter l'activité cftr | |
| BR112015010102A2 (pt) | compostos heterocíclicos substituídos por amida úteis como moduladores de respostas de il-12, il-23 e/ou ifnalfa | |
| AR074790A1 (es) | Derivados de isooxazol sustituidos, composiciones farmaceuticas y para el control de parasitos que los comprenden y su uso en metodos para controlar parasitos en y sobre animales de sangre caliente. | |
| AR059622A1 (es) | Quinolonas utiles como inhibidores de la sintetasa del oxido nitrico inducibles | |
| EA201791461A1 (ru) | Бензодиазепиновые димеры с мостиковым гетероариленом, их конъюгаты, способы получения и применение | |
| MX2021009806A (es) | Ésteres de ácidos grasos de cadena media de beta-hidroxibutirato y butanodiol y composiciones y métodos para usar los mismos. | |
| AR078535A1 (es) | Derivados de pirrolo[2,3-b]piridina ligandos de receptores estrogenicos, composiciones farmaceuticas que los contienen y uso de los mismos en el tratamiento de la osteoporosis y enfermedades del sistema nervioso central, entre otras | |
| MEP36508A (en) | Triazolopyrazine derivatives useful as anti-cancer agents | |
| CO6231036A2 (es) | Compuestos de azufre como inhibidores de la serina proteasa ns3 del virus de la hepatitis c | |
| AR054560A1 (es) | Espiropiperidina como inhibidores de beta-secretasa para el tratamiento de la enfermedad de alzheimer | |
| AR079205A1 (es) | Morfolinotiazoles como moduladores alostericos positivos alfa 7 | |
| UY31933A (es) | Compuestos de sulfoximinamida para combatir plagas animales | |
| RS54205B1 (en) | L-PROLINE AND CO-CRYSTALS OF LUMIC ACID OF (2S, 3R, 4R, 5S, 6R) -2- (3 ((5- (4-FLUOROPHENYL) THIOPHEN-2-IL) METHYL-4-METHYLPHENYL) -6- (HYDROXYMETHYL) TETRAHYDRO-2H-PYRAN-3, 4, 5-TRIOLA | |
| DK2058317T3 (da) | Aminophosphorsyreesterderivat og S1P receptormodulator indeholdende samme som aktiv ingrediens | |
| EA201591775A1 (ru) | Замещенные ароматические соединения и связанный с ними способ лечения фиброза | |
| DOP2007000014A (es) | Derivados de sulfonamidas, su preparacion y su aplicacion en terapeutica | |
| MX2010001170A (es) | Derivados de imidazolona, metodo de preparacion de los mismos y uso biologico de los mismos. | |
| PE20190339A1 (es) | 1h-pirazolo[4,3-b] piridinas como inhibidores de pde1 | |
| AR069098A1 (es) | Inhibidores macrociclicos de la ns3 serina proteasa del virus de la hepatitis c | |
| EA201300436A8 (ru) | Совместные кристаллы и соли ингибиторов ccr3 | |
| PE20220386A1 (es) | Amidas de pirazolo-piridina sustituidas y su uso como moduladores del receptor glun2b |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |